The unified social credit code/registration number of National Medicine Enshi Co., Ltd. is 91422801585471237b, and the corporate entity is Xiang Jiguang. At present, the enterprise is in the state of opening.
The business scope of National Medicine Enshi Co., Ltd. is: narcotic drugs, psychotropic drugs (Category I and II), Chinese herbal medicines, Chinese patent medicines, Chinese herbal pieces, chemical preparations, antibiotic preparations, biochemical drugs, biological products, toxic drugs for medical use (traditional Chinese medicines), in vitro diagnostic reagents, protein assimilation preparations and peptide hormones. Wholesale and retail (including refrigerated drugs), health care drugs, chemical reagents, fitness products, medical devices, family planning drugs and supplies, cosmetics and daily necessities; Disinfection products, antiviral products, health food, prepackaged foods wholesale; Warehousing, transportation information consultation and information technology services. (Licensed projects can only be operated after obtaining the permission of relevant departments). In Hubei Province, the total registered capital of companies with similar business scope is 80.82 million yuan, and the main capital is concentrated in 49 enterprises with the scale of100-1000,000. In the province, the registered capital of enterprises is excellent.
Enshi, the holding company of Sinopharm, invested 1 company and 0 branches.
See more information and information about Enshi shares of Sinopharm through Baidu Enterprise Credit.